Catalent
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Catalent and other ETFs, options, and stocks.About CTLT
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services.
CEOAlessandro Maselli
CEOAlessandro Maselli
Employees19,000
Employees19,000
HeadquartersSomerset, New Jersey
HeadquartersSomerset, New Jersey
Founded1933
Founded1933
Employees19,000
Employees19,000
CTLT Key Statistics
Market cap7.45B
Market cap7.45B
Price-Earnings ratio17.71
Price-Earnings ratio17.71
Dividend yield—
Dividend yield—
Average volume2.52M
Average volume2.52M
High today$42.00
High today$42.00
Low today$41.36
Low today$41.36
Open price$42.00
Open price$42.00
Volume760.70K
Volume760.70K
52 Week high$136.13
52 Week high$136.13
52 Week low$40.69
52 Week low$40.69
CTLT News
Yahoo Finance 1d
Should You Add Catalent to Your Portfolio for the Long-Term? - Yahoo FinanceAristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity” third quarter 2022 investor letter. A copy of the same can be download...
Simply Wall St 7d
The one-year shareholder returns and company earnings persist lower as Catalent stock falls a further 8.8% in past week - Simply Wall StInvesting in stocks comes with the risk that the share price will fall. And there's no doubt that Catalent, Inc. ( ) stock has had a really bad year. In that re...
Analyst ratings
81%
of 16 ratingsBuy
81.3%
Hold
18.8%
Sell
0%
CTLT Earnings
$0.00
$0.40
$0.79
$1.19
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Estimated— per share
Estimated— per share
ActualExpected Jan 31, Pre-Market
ActualExpected Jan 31, Pre-Market